Cargando…
Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion
With the increasing incidence of obesity and metabolic syndrome worldwide, concomitant nonalcoholic fatty liver disease (NAFLD) in patients with chronic hepatitis B (CHB) has become highly prevalent. The risk of dual etiologies, outcome, and mechanism of CHB with concomitant NAFLD have not been full...
Autores principales: | Shi, Yi-Wen, Yang, Rui-Xu, Fan, Jian-Gao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311534/ https://www.ncbi.nlm.nih.gov/pubmed/34326608 http://dx.doi.org/10.3748/wjg.v27.i26.3971 |
Ejemplares similares
-
Expert opinion on the management of hepatitis C infection in Kuwait
por: Saad, Motaz Fathy, et al.
Publicado: (2018) -
Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Hepatic Steatosis
por: Zheng, Rui-dan, et al.
Publicado: (2013) -
Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence
por: Longo, Filomena, et al.
Publicado: (2023) -
PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism
por: Pan, Qin, et al.
Publicado: (2017) -
Morphometric Analysis of Hepatic Steatosis in Chronic Hepatitis C Infection
por: Zubair, Alia, et al.
Publicado: (2009)